Table of Contents
Cancer is the second-leading cause of death and disability in the world, behind only heart disease. More people die from cancer every year around the world than AIDS, Tuberculosis and Malaria combined. Cancer testing has tremendous growth opportunities for the next five years. According to the National Cancer Institute (NCI), 85% of cancer patients are treated in community-based, private practice oncology settings. Accordingly, global expansion of cancer marker technologies may be fueled by an increased marketing of new diagnostic tests to physicians. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. The anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The global cancer test market is expected to be more than US$ 14 Billion by 2018.
Renub Research study titled “Cancer Test Market & Forecast, Companies Cancer Test Platform, Pipeline Analysis and Clinical Trials - Global” provides a comprehensive assessment of the fast-evolving, high-growth of Cancer Test market segment. This 277 page report with 52 Figures and 57 Tables studies the Cancer Test Platform of 20 Companies.
This report is broadly divided into 8 chapters.
A. Global – Cancer Testing Market and New Cases (Chapter 2)
B. Global – Cancer Testing Market Share & Forecast (Chapter 3)
C. Global – Segment Wise Cancer Testing Market & Forecast (Chapter 4)
D. Global – Organ Specific Cancer Testing Market & Forecast (Chapter 5)
E. Cancer Diagnostics – Companies Novel Test Platform Analysis (Chapter 6)
F. Geographic Region – Number of New Cancer Cases (Chapter 7)
G. Number of New Cancer Cases by Site - Geographic Region Distribution & Clinical Trials (Chapter 8)
Global – Segment Wise Cancer Testing Market (To 2018) (Chapter No. 4)
• Prostate Specific Antigen (PSA) Test Market & Forecast
• Fecal Occult Blood Test Market & Forecast
• Fluorescent In-Situ Hybridization (FISH) Test Market & Forecast
• Human Papilloma Virus (HPV) Test Market & Forecast
• Bladder Test Market & Forecast
• Serum Based Cancer Markers Market & Forecast
• Pharmacognostic Histology Market & Forecast
• Flow Cytometry Market & Forecast
• Other Test Market & Forecast
Global – Organ Specific Cancer Testing Market (To 2018) (Chapter No. 5)
• Bladder Cancer Test Market & Forecast
• Breast Cancer Test Market & Forecast
• Cervical Cancer Test Market & Forecast
• Colorectal (Colon) Cancer Test Market & Forecast
• Ovarian Cancer Test Market & Forecast
• Prostate Cancer Test Market & Forecast
• Liver Cancer Test Market & Forecast
• Flow Cytometry Market & Forecast
• Other Organ Specific Cancer Test Market & Forecast
Cancer Diagnostics – Companies Novel Test Platform Analysis (Chapter No. 6)
1 Abbott 11 Genomic Health Inc
2 Radient Pharmaceuticals 12 QIAGEN Marseille (Earlier Ipsogen)
3 BD Diagnostics 13 Myriad Genetics, Inc
4 Beckman Coulter, Inc. 14 Panacea Pharmaceuticals, Inc.
5 BioCurex 15 Qiagen
6 bioMerieux 16 Siemens Heathcare Diagnostics
7 Cepheid 17 Roche
8 CytoCore Inc. 18 Ventana Medical Systems
9 DiagnoCure, Inc 19 Trovagene Inc
10 Gen-Probe, Inc. 20 Vermillion, Inc
Geographic Region – Number of New Cancer Cases (To 2020) (Chapter No. 7)
Number of New Cancer Cases by Site - Geographic Region Distribution (To 2020) (Chapter 8)
1 Bladder Cancer 15 Myeloma
2 Brain Cancer 16 Nasopharynx
3 Breast Cancer 17 Non-Hodgkin Lymphoma
4 Cervix Cancer 18 Oesophagus
5 Colorectal Cancer 19 Oral Cavity
6 Corpus Cancer 20 Other Pharynx
7 Hodgkin’s Lymphoma 21 Ovary Cancer
8 Kaposi Sarcoma 22 Pancreas Cancer
9 Kidney Cancer 23 Prostate Cancer
10 Larynx Cancer 24 Stomach Cancer
11 Leukaemia 25 Testis Cancer
12 Liver Cancer 26 Thyroid Cancer
13 Lung Cancer 27 Other Sites
Cancer Site - Clinical Trials (Chapter 8)
1. Bladder Cancer
2. Cervical Cancer
3. Colorectal Cancer
4. Liver Cancer
5. Ovarian Cancer
6. Prostate Cancer
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts.
Primary sources include industry surveys and telephone interviews with industry experts.
Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.
Get Industry Insights. Simply.
Talk to Veronica
+1 718 514 2762
PharmaPoint: Colorectal Cancer - Global Drug Forecast and Market Analysis to 2025 Summary Colorectal Cancer (CRC) Market, considering the sales of both branded treatments and generic chemotherapy, is expected ...
Use this report to: - Analyze the global prostate cancer market, with important statistics and analysis on existing drugs, and diagnostic technologies. - Receive information on regulatory environment, ...
Global Prostate Cancer Therapeutics Market: Overview This report on the prostate cancer therapeutics market analyzes the current and future scenario of the global market. Increasing prevalence of prostate ...